# Molecular-Docking-of-Erlotinib
An AutoDock-based docking study evaluating Erlotinib binding to the EGFR tyrosine kinase domain (PDB 1M17). Workflow includes ligand/receptor separation, grid preparation, Lamarckian Genetic Algorithm docking, and comparative analysis of binding energies, RMSD clustering, and interaction mapping.
